Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;14(4):4659-4662.
doi: 10.3892/ol.2017.6823. Epub 2017 Aug 24.

Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways

Affiliations

Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways

Sheng Chen et al. Oncol Lett. 2017 Oct.

Abstract

We aimed to investigate the influence of long non-coding RNA (lncRNA) PTEN pseudogene-1 (PTENP1) on the proliferation, migration and cycle of breast cancer cells and its mechanism. Lentiviral vectors expressing PTENP1 were synthesized and breast cancer cells MCF7 were transfected with LV003-GFP-PTENP1 and LV003-GFP, respectively. The proliferation capacities of breast cancer cells were detected using CCK-8 assay, and the migration capacities of breast cancer cells were detected using scratch assay; flow cytometry was used to detect the cell cycles and Western blot was used to detect the expression levels of cyclin A2, CDK2, p-p44/42 MAPK, t-p44/42 MAPK, p-p38 MAPK, t-p38 MAPK, p-AKT, t-AKT in AKT and MAPK pathways. The absorbance values (A450) of cells in experimental group at 48 and 72 h were 1.4±0.3 and 2.3±0.47, respectively, which were significantly lower than those in control group (3.2±0.39, 3.4±0.58) (P<0.05). The number of cell colonies in experimental group was (48±13), which was significantly lower than that in control group (159±16) (P<0.01). The cell migration rate in experimental group was 22.8±3.3%, which was significantly lower than that in control group 61.8±5.2% (P<0.01). Western blot detection showed that the expression levels of cyclin A2, CDK2, p-AKT, p-p44/42 MAPK and p-p38 MAPK in experimental group were significantly decreased compared with those in control group. LncRNA PTENP1 can inhibit the proliferation and migration of breast cancer cells via the AKT and MAPK signaling pathways.

Keywords: PTENP1; breast cancer; cell cycle; lncRNA; migration.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The growth curve of breast cancer MCF7 cells.
Figure 2.
Figure 2.
Colony-forming assay of breast cancer MCF7 cells. (A) Control group; (B) experimental group; (C) compared with control group, colony number was significantly reduced in the experimental group (**P<0.01).
Figure 3.
Figure 3.
Influence of lncRNA PTENP1 on migration capacity of breast cancer MCF7 cells between control group and experimental group (**P<0.01).
Figure 4.
Figure 4.
Influence of lncRNA PTENP1 on cyclin of breast cancer MCF7 cells between control group and experimental group.
Figure 5.
Figure 5.
Influence of lncRNA PTENP1 on AKT and MAPK signaling pathways of breast cancer MCF7 cells between control group and experimental group.

Similar articles

Cited by

References

    1. Shi Y, Yang F, Sun Z, Zhang W, Gu J, Guan X. Differential microRNA expression is associated with androgen receptor expression in breast cancer. Mol Med Rep. 2017;15:29–36. doi: 10.3892/mmr.2016.6019. - DOI - PMC - PubMed
    1. Marzese DM, Gago FE, Vargas-Roig LM, Roqué M. Methylation profile of human breast cancer: A possible biomarker for the detection of circulating tumor cells. J Clin Oncol. 2009;27(Suppl 15):11112.
    1. Yu X, Li Z. Long non-coding RNA HOTAIR: A novel oncogene (Review) Mol Med Rep. 2015;12:5611–5618. doi: 10.3892/mmr.2015.4161. - DOI - PubMed
    1. Perez-Tenorio G, Alkhori L, Olsson B, Waltersson MA, Nordenskjöld B, Rutqvist LE, Skoog L, Stål O. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res. 2007;13:3577–3584. doi: 10.1158/1078-0432.CCR-06-1609. - DOI - PubMed
    1. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95:29–39. doi: 10.1016/S0092-8674(00)81780-8. - DOI - PubMed